Status:

ACTIVE_NOT_RECRUITING

A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients

Lead Sponsor:

Prestige Biopharma Limited

Conditions:

Lung Cancer

Non-small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin®. The aim of the study is to demonstrate equivalence of HD204 and EU-licensed Avastin...

Detailed Description

This is a randomised, double-blind, parallel group, equivalence, multicentre Phase III study in patients with metastatic or recurrent non-squamous non-small cell lung cancer (NSCLC). Standard efficac...

Eligibility Criteria

Inclusion

  • Aged ≥ 18 years
  • ECOG performance status of 0-1
  • Histologically-confirmed metastatic or recurrent non-squamous non-small cell lung cancer
  • At least one measurable lesion according to RECIST v1.1.
  • Able to receive bevacizumab, carboplatin and paclitaxel based on adequate laboratory and clinical parameters

Exclusion

  • Diagnosis of small cell carcinoma of the lung or squamous cell carcinoma
  • Sensitizing EGFR mutations or ALK rearrangements
  • Increased risk of bleeding determined by investigator based on radiographic / clinical findings
  • History of systemic chemotherapy administered in the first-line setting for metastatic or recurrent disease of NSCLC.

Key Trial Info

Start Date :

November 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2025

Estimated Enrollment :

650 Patients enrolled

Trial Details

Trial ID

NCT03390686

Start Date

November 15 2019

End Date

December 1 2025

Last Update

May 31 2025

Active Locations (18)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (18 locations)

1

Alexandrov Cancer Center

Minsk, Minsk City, Belarus, 223040

2

MHAT "Dr. Tota Venkova", AD

Gabrovo, Bulgaria, 5300

3

CHC Osijek

Osijek, Osijecko-baranjska, Croatia, 31000

4

LTD "High Technology Hospital Medcenter"

Batumi, Georgia, 6010